Therapeutic Education for Harm Reduction in People With Alcohol Use Disorder

NCT ID: NCT03954054

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-28

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alcohol is the most harmful psychoactive substance in terms of overall damage. Although abstinence remains the objective of most pharmacological and non-pharmacological approaches addressing alcohol use disorder (AUD), new therapeutic objectives of reduced alcohol intake and controlled-drinking have emerged.

ETHER ("Education THEérapeutique pour la Réduction des dommages en alcoologie" or therapeutic education for the reduction of alcohol-related harms) is an ongoing, multicentre, community-based mixed-methods study, which aims to evaluate the innovative therapeutic patient education (TPE) programme named "Choizitaconso". This programme teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.

The evaluation of the programme will rely on a sequential explanatory design, where the qualitative study (16 semi-structured interviews) will assist in explaining and interpreting the findings of the controlled before-and-after quantitative study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ETHER's quantitative component is a 6-month controlled study which evaluates the effectiveness of "Choizitaconso" by comparing 30 PWAUD following the programme with a control group of 60 PWAUD not following it. All 90 PWAUD are individually interviewed using standardized face-to-face and phone-based interviews.

34 questions on alcohol-related harms were identified in the international literature and approved by the PWAUD community. The sum of these harms, considered as a measure of the individual "burden" related to alcohol use, will be used as principal outcome.

Secondary outcomes are quantity and frequency of alcohol consumption, craving for alcohol, coping strategies, Health-Related Quality of Life (HRQL), self-confidence to resist drinking, anticipated and internalized stigma, treatment self-regulation, anxiety and depressive symptoms, alcohol-related neuropsychological impairments and capabilities (i.e., a measure of wellbeing for the general adult population, used in economic evaluations).

Primary and secondary outcomes will be collected in face-to-face and phone-based interviews at enrolment and 6 months after enrolment. We will use a binomial test and linear regression models to assess the impact of the TPE programme on changes in the principal and secondary outcomes, while adjusting for other correlates and confounders.

The study's qualitative component comprises semi-structured interviews of 16 PWAUD who completed the TPE programme at least 6 months before the interview. Qualitative interviews will be analysed using thematic analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Former therapeutic education participants

Semi-structured interviews with people who already completed the TPE programme

"Choizitaconso" - therapeutic patient education programme

Intervention Type BEHAVIORAL

Choizitaconso is a therapeutic patient education programme that teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.

It lasts for 10 weeks for each participant and consists of the following 5 modules, including one optional module focusing on the family environment:

1. Understand the mechanisms that trigger and/or maintain alcohol-related difficulties
2. Plan and evaluate personalized controlled drinking strategies
3. Understand and identify external and internal influences (e.g., thoughts and emotions), identify and manage risk situations
4. Identify alcohol effects and alcohol-related expectations (by developing self-observation skills)
5. Family environment: learning how to evaluate and take care of oneself (e.g., how to express feelings)

Each module consists of 2 to 4 collective workshops that each last 120 minutes and involve 5 to 10 persons.

Intervention group (current therapeutic education participants)

A face-to-face interview and a telephone interview at treatment initiation (M0) and 6 months after programme initiation (M6)

Administration of socio-economic questionnaires and a Brief Evaluation of Alcohol-Related Neuropsychological Impairment (BEARNI) before, and 6 months after inclusion in the therapeutic education programme.

"Choizitaconso" - therapeutic patient education programme

Intervention Type BEHAVIORAL

Choizitaconso is a therapeutic patient education programme that teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.

It lasts for 10 weeks for each participant and consists of the following 5 modules, including one optional module focusing on the family environment:

1. Understand the mechanisms that trigger and/or maintain alcohol-related difficulties
2. Plan and evaluate personalized controlled drinking strategies
3. Understand and identify external and internal influences (e.g., thoughts and emotions), identify and manage risk situations
4. Identify alcohol effects and alcohol-related expectations (by developing self-observation skills)
5. Family environment: learning how to evaluate and take care of oneself (e.g., how to express feelings)

Each module consists of 2 to 4 collective workshops that each last 120 minutes and involve 5 to 10 persons.

Control AUD (Alcohol Use Disorder) patients

A face-to-face interview and a telephone interview at treatment initiation (M0) and 6 months after programme initiation (M6)

Administration of socio-economic questionnaires and a Brief Evaluation of Alcohol-Related Neuropsychological Impairment (BEARNI) before, and 6 months after inclusion in the therapeutic education programme.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

"Choizitaconso" - therapeutic patient education programme

Choizitaconso is a therapeutic patient education programme that teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.

It lasts for 10 weeks for each participant and consists of the following 5 modules, including one optional module focusing on the family environment:

1. Understand the mechanisms that trigger and/or maintain alcohol-related difficulties
2. Plan and evaluate personalized controlled drinking strategies
3. Understand and identify external and internal influences (e.g., thoughts and emotions), identify and manage risk situations
4. Identify alcohol effects and alcohol-related expectations (by developing self-observation skills)
5. Family environment: learning how to evaluate and take care of oneself (e.g., how to express feelings)

Each module consists of 2 to 4 collective workshops that each last 120 minutes and involve 5 to 10 persons.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least 18 years old
* fluent in French speaker
* able to provide written, informed consent
* reachable by phone
* followed-up for Alcohol Use Disorder

Exclusion Criteria

* cocaine or opiate dependence
* being a legally-protected adult (tutorship, curatorship)
* being pregnant
* participation in another study during the duration of follow-up (6 months)
* having severe cognitive impairment which could conflict with successful group work
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Regional Agency for Health PACA

OTHER

Sponsor Role collaborator

SESSTIM UMR1252 (Aix-Marseille Univ, INSERM, IRD)

UNKNOWN

Sponsor Role collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CSAPA Convergence

Avignon, , France

Site Status

ANPAA 04

Digne-les-Bains, , France

Site Status

Clinique Saint Barnabé

Marseille, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Barre T, Ramier C, Antwerpes S, Costa M, Bureau M, Maradan G, Di Beo V, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Dufort S, Protopopescu C, Marcellin F, Casanova D, Coste M, Carrieri P. A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study). Drug Alcohol Rev. 2023 Mar;42(3):664-679. doi: 10.1111/dar.13605. Epub 2023 Jan 31.

Reference Type RESULT
PMID: 36721903 (View on PubMed)

Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barre T, Casanova D, Carrieri P. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Harm Reduct J. 2022 Jan 10;19(1):2. doi: 10.1186/s12954-021-00587-0.

Reference Type RESULT
PMID: 35012570 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C19-03 / ETHER

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Blended Treatment for Alcohol Use Disorder
NCT04535258 ACTIVE_NOT_RECRUITING NA
LDART for Alcohol Use Disorder
NCT07221383 NOT_YET_RECRUITING NA